Ophthalmology · Tonawanda, NY
NPI
1487642682
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1890 Colvin Blvd
Tonawanda, NY, 14150
Phone (716) 837-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
2,676 services
Medicare patients, 2024
644
Average age 78
Drug cost, 2024
$1.8M
4,570 prescriptions
Company payments, 2025
$2,706
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas A Stathopoulos was code 92014 (ophthalmological e&m), 497 times for 490 patients. In total Nicholas A Stathopoulos billed 2,676 services in 31 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 497 | 490 | $77.44 | $38K |
| 92250 Angiography | Office | 489 | 484 | $24.54 | $12K |
| 99214 Office E&M - Established | Office | 446 | 342 | $82.33 | $37K |
| 92134 Computerized Ophthalmic Imaging | Office | 229 | 226 | $26.95 | $6,172 |
| 92083 Vision, Hearing, and Speech Services | Office | 189 | 185 | $41.17 | $7,782 |
| 92133 Computerized Ophthalmic Imaging | Office | 157 | 154 | $23.69 | $3,719 |
| 92020 Ophthalmological E&M | Office | 133 | 133 | $19.03 | $2,531 |
| 99213 Office E&M - Established | Office | 127 | 98 | $62.04 | $7,879 |
| 92136 Ultrasound - Nonspecific | Office | 104 | 41 | $17.35 | $1,804 |
| 66984 Cataract Surgery | Facility | 62 | 35 | $409.14 | $25K |
| 92012 Ophthalmological E&M | Office | 56 | 52 | $50.93 | $2,852 |
| 68761 Eye | Office | 40 | 20 | $82.34 | $3,294 |
| 92004 Ophthalmological E&M | Office | 32 | 32 | $89.41 | $2,861 |
| 66821 Cataract Surgery | Office | 19 | 18 | $250.04 | $4,751 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 17 | 12 | $178.70 | $3,038 |
By year: 2022 $164K for 2,736 services; 2023 $183K for 2,754 services; 2024 $174K for 2,676 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas A Stathopoulos prescribed most often to Medicare patients was Cyclosporine, with 926 prescriptions and refills. In total Nicholas A Stathopoulos wrote 4,570 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cyclosporine Generic | 926 | 2,226 | 493 | $605K |
| Latanoprost Generic | 684 | 1,708 | 213 | $17K |
| Fluorometholone Generic | 469 | 539 | 390 | $56K |
| Erythromycin Erythromycin Base | 351 | 371 | 158 | $4,991 |
| Xiidra Lifitegrast | 275 | 647 | 112 | $425K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 243 | 603 | 71 | $8,694 |
| Lumigan Bimatoprost | 199 | 432 | 57 | $123K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 173 | 182 | 145 | $2,680 |
| Restasis Cyclosporine | 168 | 451 | 96 | $268K |
| Miebo Perfluorohexyloctane/Pf | 154 | 154 | 37 | $118K |
| Bimatoprost Generic | 111 | 222 | 33 | $15K |
| Loteprednol Etabonate Generic | 101 | 144 | 66 | $29K |
| Brimonidine Tartrate Generic | 80 | 180 | 27 | $22K |
| Dorzolamide Hcl Generic | 60 | 113 | 17 | $1,386 |
| Bromfenac Sodium Generic | 54 | 68 | 14 | $13K |
Brand drugs: - claims; generic drugs: 2,294 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas A Stathopoulos $2,706 ($2,706 in general payments such as food, travel and fees) from 13 companies. The largest payer was Alcon Vision LLC with $798.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 34 | $798 |
| Bausch & Lomb Americas Inc. BLCO | 18 | $413 |
| Glaukos Corporation GKOS | 5 | $328 |
| Tarsus Pharmaceuticals, Inc. TARS | 13 | $317 |
| Oyster Point Pharma, Inc. | 10 | $221 |
| Amgen Inc. AMGN | 4 | $196 |
| Abbvie Inc. ABBV | 6 | $164 |
| Harrow Eye, LLC | 4 | $73.62 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 3 | $60.28 |
| Biotissue Holdings Inc. | 3 | $54.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.